Primacef-Aversi 1g intravenously, intramuscularly №1

Use - Primacef (Cefepime) is indicated for the treatment of infections caused by susceptible bacteria, including hospital-acquired and community-acquired pneumonia. - It is used for acute bacterial exacerbation of chronic bronchitis and acute bronchitis. - Effective for complicated and uncomplicated urinary tract infections. Used for the treatment of uncomplicated skin and skin structure infections. - Applied in complicated intra-abdominal infections, in combination with metronidazole. - Prescribed for empirical treatment of patients with febrile neutropenia. - Also used in patients at high risk of developing severe infection, including those who have undergone bone marrow transplantation, have preoperative hypotension, suffer from hemoblastosis, or have severe/prolonged neutropenia. How to take - The drug is administered intramuscularly (IM) or intravenously (IV). - The intravenous route of administration is preferred for patients with severe or life-threatening infections, especially in cases of shock. - For adults and children weighing more than 40 kg and with normal kidney function, a single dose is 0.5-1 g, with an interval of 12 hours between administrations. Contraindications - Hypersensitivity to cefepime, cephalosporin class antibiotics, penicillins, or other beta-lactam antibiotics.